The authors enrolled 714 pregnant women with third trimester PROM and PPROM (577 women with PROM, 116 with late PPROM at 32e36 þ6 weeks, and 21 women with early PPROM, < 32 weeks' gestation) in the Jiangsu Province Hospital between January and December 2015, to study maternal characteristics and pregnancy outcomes. 6 The authors found that breech presentation and history of previous cesarean section was associated with occurrence of PPROM compared to that of PROM (9.5% vs. 1.9% and 14.6% vs. 4.7%, respectively; both p < 0.01). 6 In addition, high C-reactive protein levels and high maternal temperature were also found in the pregnant women with PPROM, suggesting that these indicate asymptomatic infection. 6 Therefore, they suggested that this condition requires close monitoring to prevent adverse effects on pregnancy. Finally, they found that longer latency period in the PPROM group is predictable, and it is important to prolong the gestational age in PPROM patients. 6 This study confirmed that accurate assessment of gestational age and understanding of the maternal, fetal, and neonatal risks are essential to appropriate evaluation, counseling, and care of patients with PROM and PPROM. 1 This article is interesting and worthy of discussion.
First, it was unfair to enroll the pregnant women with PROM in Chandra and Sun's study. One trial revealed that for 50% of women with PROM who were managed with an expectation of delivery within 5 hours, 95% of those patients delivered within 28 hours. 7 The meta-analysis data (6814 pregnant women with PROM at 37 weeks of gestation or more) indicated that these pregnant women benefitted from induction of labor compared with expectant management, based on the findings that induction of labor reduced the time to delivery and the rates of chorioamnionitis, endometritis, and admission to the neonatal intensive care unit, without increasing the rates of cesarean section or operative vaginal delivery. 8 Second, the optimal gestational age for delivery is unclear and controversial in pregnant women with PPROM, 1 especially for those patients with late PPROM. 1 The definition of late preterm birth often ranges from 34 weeks' to 37 weeks' gestation. 9 It is unusual to use 32 weeks' gestation as a cutoff value, as shown by Chandra and Sun. 6 For example, recent new information from a meta-analysis and randomized controlled trials evaluated delivery versus expectant management between 34 weeks' and 37 weeks' gestation (late preterm birth) also failed to show a significant difference between the two groups. 10, 11 Analysis of the cost-effectiveness of the randomized controlled trial of preterm prelabor rupture of the membranes near term found that there was no significant difference between immediate birth and expectant management. 12 Based on the above-mentioned findings, we might conclude that expectant medical management might be the better choice for women with late PPROM, and that induction of labor might be a superior choice for women with PROM. Unfortunately, Chandra and Sun did not provide any new information for us in this regard.
Third, Chandra and Sun suggested monitoring for asymptomatic infection and longer latency period for PPROM to minimize perinatal morbidity and mortality. Of course, it is gratifying to learn that research studies have focused on more accurate clinical and/or microbiological surveillance systems, validated risk stratification strategies, and better point-of-care testing for women with early PPROM (< 34 weeks' gestation), to offer improved intervention to minimize the risk of maternal and fetal morbidity and mortality. Unfortunately, Chandra and Sun provided little information in this regard. 6 In addition, the following concepts are clear indications for delivery, such as nonreassuring fetal status, clinical chorioamnionitis, and significant placental abruption. 1 Chandra and Sun also missed this important point.
Finally, Chandra and Sun did not perform routine culturing for patients with PPROM, and they also failed to mention any Group B Streptococcus (GBS) screening. GBS screening is a highly recommended procedure for pregnant women, and vaginal macrobiotics is an important issue for preterm births. 13e15 The recent clinical management guidelines from the American College of Obstetricians and Gynecologist for obstetricians and gynecologists recommend the following to reduce maternal and neonatal infection and gestational-agedependent morbidity: (1) a 7-day course of combination therapy of intravenous ampicillin and erythromycin followed by oral amoxicillin and erythromycin in women with early PPROM; (2) a single course of corticosteroids; (3) the needs of intrapartum GBS prophylaxis; and (4) at risk of imminent delivery, magnesium sulfate might be used for fetal neuroprotection. 1 
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